Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review. Your provider may recommend certain doses of Compound Semaglutide based on your medical evaluation.
Compounded semaglutide is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off. It should be used with a reduced-calorie diet and increased physical activity.
Compounded semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of:
Compounded semaglutide should not be used with other semaglutide-containing products or any GLP-1 receptor agonist medicines. It is not known if semaglutide is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products. It is not known if semaglutide can be used in people who have had pancreatitis. It is not known if semaglutide is safe and effective for use in children under 18 years of age.
Compounded semaglutide is not FDA approved and does not undergo the same rigorous efficacy and safety checks as do FDA-approved medications. Compounded semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist which may be used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of:
Note: Compounded medications are not FDA approved and do not have indications for treatment as an FDA approved medication would. The above are suggestions for use of compounded semaglutide while the FDA approved therapies remain on shortage.
Do not use Compounded Semaglutide if:
You can take compounded semaglutide with or without food. The pre-filled injector pen is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. Your provider will guide you on a treatment regimen that may include an increase in dose every four weeks.
You should not change your dosing regimen or stop taking compounded semaglutide as prescribed without discussing with your provider first.
In particular, tell your provider if you have a past history of:
Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.
If you are experiencing a medical emergency, call 911 or seek immediate medical attention.
These serious side effects can occur with compounded semaglutide. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.
You are encouraged to report negative side effects of prescription products to the FDA.
Visit fda.gov/medwatch or call 1-800-FDA-1088.
Compounded semaglutide is a prescription medicine. For more information on semaglutide-containing products, please call 877-581-2210 to learn more or receive information regarding how to contact your pharmacy.
This summary provides basic information about compounded semaglutide but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about compounded semaglutide and how to take it. Your healthcare provider is the best person to help you decide if compounded semaglutide is right for you.
Disclaimer: Ozempic®, WeGovy®, Saxenda® and Victoza® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly. Byetta® and Bydureon® are registered trademarks of Amylin Pharmaceuticals. Brightmeds has no affiliation with Novo Nordisk, Eli Lilly or Amylin Pharmaceuticals. The compounded products available as part of our Weight Loss Program are not made by Novo Nordisk, Eli Lilly or Amylin Pharmaceuticals or any company affiliated with Novo Nordisk, Eli Lilly or Amylin Pharmaceuticals.
All-in-one service to get fast access to compounded semaglutide & tirzepatide weight loss medication.
1 In a clinical trial , the participants with BMI 30 or more, or 27 or more with at least one weight-related condition, the average participant lost 20.9% of body weight during the 72-week trial.
2 In a clinical trial , the participants with BMI 30 or more, or 27 or more with at least one weight-related condition, the average participant lost 14.9% of body weight during the 68-week trial.
Weight loss study results like the above may vary for oral semaglutide due to potential differences in formulation and dosing. Licensed medical professionals, including Brightmeds-affiliated physicians, can prescribe oral semaglutide after medical evaluation to aid in weight management. For personalized guidance, we recommend consulting with a healthcare provider.
*Important Notice: The recognized brand name medication approved by the FDA, Zepbound™ and Mounjaro® is manufactured by Eli Lilly and Company™, and Wegovy® and Ozempic® is manufactured by Novo Nordisk™. We do NOT manufacture this medication and have no direct affiliation with either Eli Lilly and Company™or Novo Nordisk™. Upon patient request, our partner pharmacies can supply the above mentioned brand name medication, however they are subject to availability.
Regarding compounded medications, our company works with sterile compounding pharmacies. These facilities undergo strict inspections, but because the compounded pharmaceuticals they produce are made according to a prescription from a specific practitioner for a particular patient, they are not FDA-approved. It might be challenging to directly compare the results and risk profiles of FDA-approved and compounded pharmaceuticals due to differences in strength, dose, and other factors. The medical judgment of a licensed clinician, based on a telemedicine interaction and medical history, determines the prescription of any compounded medication.
100% money back guarantee if your prescription is not approved; brightmeds.com does not directly offer medical or pharmacy services. We partner with medical professionals who use HIPAA-compliant platforms to deliver services. This website’s content is meant only as a source of information; it should not be used as a substitute of expert medical advice, evaluation, or care. Please contact your doctor if you have any questions or concerns regarding your health.
Copyright 2024 Brightmeds.com